higher cumulative and average daily caffeine exposure are associated with improved neurodevelopmental
outcomes in preterm infants. We identiÔ¨Åed dosing regimens that
would deliver the median ADCE (5.1 mg/kg) of the high dose
group to infants born at a range of gestational ages. The goal
minimum ADCE is achievable for all ages with a caffeine bolus of